NXTC / NextCure, Inc. - Net Long/Short Value

NextCure, Inc.

NXTC / NextCure, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Vanguard Capital Management Llc
UBS Group AG
Silverarc Capital Management, Llc
Verdad Advisers, LP
Acadian Asset Management Llc
Citigroup Inc
Woodline Partners LP
Ikarian Capital, LLC
Morgan Stanley
Pfizer Inc
Boothbay Fund Management, Llc
Sofinnova Investments, Inc.
Vanguard Fiduciary Trust Co
Jpmorgan Chase & Co
Barclays Plc
Geode Capital Management, Llc
Citadel Advisors Llc
AWM Investment Company, Inc.
Opaleye Management Inc.
Squadron Capital Management LLC
Affinity Asset Advisors, LLC
Vanguard Group Inc
Bnp Paribas Arbitrage, Sa
Cardiff Park Advisors, Llc
BlackRock, Inc.
Renaissance Technologies Llc
Exome Asset Management LLC
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista